AGILE-ACCORD: A Randomized, Multicentre, Seamless, Adaptive Phase I/II Platform Study to Determine the Optimal Dose, Safety and Efficacy of Multiple Candidate Agents for the Treatment of COVID-19: A structured summary of a study protocol for a randomised platform trial.
Trials
; 21(1): 544, 2020 Jun 19.
Article
in En
| MEDLINE
| ID: mdl-32560744
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Antiviral Agents
/
Pneumonia, Viral
/
Randomized Controlled Trials as Topic
/
Coronavirus Infections
/
Betacoronavirus
Type of study:
Clinical_trials
/
Guideline
/
Prognostic_studies
Limits:
Humans
Language:
En
Journal:
Trials
Journal subject:
MEDICINA
/
TERAPEUTICA
Year:
2020
Document type:
Article
Affiliation country:
Country of publication: